Theme 07: Screening and Early Detection

Screening and Early Detection Infrastructures for screening and early detection aim to create systems that facilitate and ensure equal access to screening, interventions, and research, particularly targeting high-risk groups. These infrastructures also include initiatives for raising awareness about the importance of early detection and diagnostics.

The CCI promotes that data from Screening and Early Detection is linked to the national / regional cancer screening registry       

Level 1

SE111
Initial discussions have taken place for the development of a national/regional cancer screening registry.

SE112
Initial discussions have taken place on how screening and early detection data can be linked to the national/regional cancer screening registry.

Level 2

SE121
The first version of a national/regional cancer screening registry is operational, and the collection of screening and early detection research data has begun.

SE122
Screening and early detection data are linked to the national/regional cancer screening registry in parts of the CCI.

Level 3

SE131
Quality assurance is in place for reporting screening and early detection research data into the national/regional cancer screening registry, ensuring regular data reporting, compliance and evaluation.

SE132
Screening and early detection data are linked to the national/regional cancer screening registry in the whole CCI.

Level 4

SE141
Data from national/regional cancer screening registry is used in screening and early detection research.

Governance of screening and early detection   

Level 1

SE113
There are national/regional guidelines for screening available.

SE114
Initial discussions to identify the unit/team responsible for coordinating early detection efforts within the CCI have taken place.

Level 2

SE123
Defined timelines are in place to ensure actions from screening to intervention.

SE124
The unit/team responsible for coordinating early detection efforts within the CCI has been identified.

Level 3

SE133
There are national/regional guidelines for early detection available.

SE134
The targeted groups of screening programs are invited to participate in screening.

Level 4

SE142
The responsible unit/team is actively involved in governing and coordinating early detection efforts within the CCI. Its role and responsibilities are periodically reviewed and optimized.

SE143
A program for the detection and monitoring of individuals with increased risk of cancer established.

SE144
Early detection practices within the CCI are implemented according to the national/regional guidelines, striving to align with EU guidelines.

Participation and collaborations in national and/or international networks 

Level 1

SE115
Initial discussions to participate in screening and early detection expert networks, have taken place.

Level 2

SE125
There are agreements and protocols for participation in screening and early detection expert networks in parts of the CCI.

Level 3

SE135
There are agreements and protocols for participation in screening and early detection expert networks in the whole CCI.

Level 4

SE145
The CCI is actively shaping and guiding expert network activities, supports involvement in clinical trials, resulting in continuous innovation, driving the development of new models, research, and outcomes.

Level 1 Level 2 Level 3 Level 4
The CCI promotes that data from Screening and Early Detection is linked to the national / regional cancer screening registry       

SE111
Initial discussions have taken place for the development of a national/regional cancer screening registry.

SE112
Initial discussions have taken place on how screening and early detection data can be linked to the national/regional cancer screening registry.

SE121
The first version of a national/regional cancer screening registry is operational, and the collection of screening and early detection research data has begun.

SE122
Screening and early detection data are linked to the national/regional cancer screening registry in parts of the CCI.

SE131
Quality assurance is in place for reporting screening and early detection research data into the national/regional cancer screening registry, ensuring regular data reporting, compliance and evaluation.

SE132
Screening and early detection data are linked to the national/regional cancer screening registry in the whole CCI.

SE141
Data from national/regional cancer screening registry is used in screening and early detection research.

Governance of screening and early detection   

SE113
There are national/regional guidelines for screening available.

SE114
Initial discussions to identify the unit/team responsible for coordinating early detection efforts within the CCI have taken place.

SE123
Defined timelines are in place to ensure actions from screening to intervention.

SE124
The unit/team responsible for coordinating early detection efforts within the CCI has been identified.

SE133
There are national/regional guidelines for early detection available.

SE134
The targeted groups of screening programs are invited to participate in screening.

SE142
The responsible unit/team is actively involved in governing and coordinating early detection efforts within the CCI. Its role and responsibilities are periodically reviewed and optimized.

SE143
A program for the detection and monitoring of individuals with increased risk of cancer established.

SE144
Early detection practices within the CCI are implemented according to the national/regional guidelines, striving to align with EU guidelines.

Participation and collaborations in national and/or international networks 

SE115
Initial discussions to participate in screening and early detection expert networks, have taken place.

SE125
There are agreements and protocols for participation in screening and early detection expert networks in parts of the CCI.

SE135
There are agreements and protocols for participation in screening and early detection expert networks in the whole CCI.

SE145
The CCI is actively shaping and guiding expert network activities, supports involvement in clinical trials, resulting in continuous innovation, driving the development of new models, research, and outcomes.

There is ongoing research on screening and early detection and implementation of new discoveries within the CCI.

Level 1

SE211
Initial discussions about funding for research in screening and early detection mechanisms and identification of potential funding have taken place.

SE212
The CCI has recognized the potential of state-of-the-art technologies for research in screening and early detection but not yet implemented any.

Level 2

SE221
The CCI has secured funding mechanisms for research in screening and early detection.

SE222
State-of-the-art technologies for research in screening and early detection have been adopted in parts of the CCI.

Level 3

SE231
Funding mechanisms are sustainable and continuously support research in screening and early detection efforts of the CCI.

SE232
State-of-the-art technologies for research in screening and early detection are fully integrated into the whole CCI.

Level 4

SE241
Multiple funding sources, including government, private, and collaborative funding, are established and diversified for research in screening and early detection.

SE242
The CCI adopts, develops and contributes to the evaluation of state-of-the-art technologies for research in screening and early detection.

Level 1 Level 2 Level 3 Level 4
There is ongoing research on screening and early detection and implementation of new discoveries within the CCI.

SE211
Initial discussions about funding for research in screening and early detection mechanisms and identification of potential funding have taken place.

SE212
The CCI has recognized the potential of state-of-the-art technologies for research in screening and early detection but not yet implemented any.

SE221
The CCI has secured funding mechanisms for research in screening and early detection.

SE222
State-of-the-art technologies for research in screening and early detection have been adopted in parts of the CCI.

SE231
Funding mechanisms are sustainable and continuously support research in screening and early detection efforts of the CCI.

SE232
State-of-the-art technologies for research in screening and early detection are fully integrated into the whole CCI.

SE241
Multiple funding sources, including government, private, and collaborative funding, are established and diversified for research in screening and early detection.

SE242
The CCI adopts, develops and contributes to the evaluation of state-of-the-art technologies for research in screening and early detection.

Identification of Screening Population

Level 1

SE311
Various types of population-based screening programs are considered, but they have not yet been implemented (e.g., breast, bowel, cervical).

Level 2

SE321
Age range-based screening programs have been developed and are being implemented.

Level 3

SE331
Targeted screening programs have been implemented. The screening population reach is over 70%.

SE333
Non-participating individuals have been identified and strategies to encourage participation are worked on.

SE334
Initial cost-effectiveness assessments have been conducted, providing insights into the efficiency of screening programs.

Level 4

SE341
Over 85% of the population, is consistently reached with screening programs of the CCI.

SE342
Targeted screening programs have been implemented for individuals with increased risk of cancer.

SE343
Strategies to engage non-participating individuals are implemented.

SE344
More detailed and regular cost-effectiveness assessments are conducted to identify areas for improvement and resource allocation to enhance the efficiency of screening programs.

SE345
The CCI actively collaborates in data analysis of data from the screening population, contributing to research and continuous improvement efforts.

Continuous education and training in screening and early detection of professionals, patients, and citizens

Level 1

SE312
Initial discussions have taken place about educating primary healthcare professionals on early detection.

SE313
First information on training programs for professionals related to the identification of high-risk populations was collected.

SE314
Initial discussions have taken place about educating patients in screening programs.

SE315
Initial discussions have taken place about educating patients in early detection.

SE316
Initial discussions about citizens' awareness have taken place.

Level 2

SE323
Training programs for primary healthcare professionals have been developed and are being implemented to enhance early detection skills.

SE324
Formal training programs for professionals focused on the identification of high-risk populations have been established within the CCI.

SE325
Education in screening programs for patients are available in parts of the CCI.

SE326
Education in early detection for patients is available in parts of the CCI.

SE327
Citizens' awareness campaigns are performed in parts of the CCI.

Level 3

SE335
Regular assessments of training programs in screening and early detection are conducted, and improvements are made based on feedback from professionals.

SE336
Education in screening programs for patients is available in the whole CCI.

SE337
Education in early detection for patients is available in the whole CCI.

SE338
Citizens' awareness campaigns are performed in the whole CCI.

Level 4

SE346
Training programs are continuously refined and updated to align with the latest guidelines and best practices on screening and early detection.

SE347
Patient education is continuously refined and updated to align with the latest advancements in screening programs.

SE348
Patient education is continuously refined and updated to align with the latest advancements in early detection.

Level 1 Level 2 Level 3 Level 4
Identification of Screening Population

SE311
Various types of population-based screening programs are considered, but they have not yet been implemented (e.g., breast, bowel, cervical).

SE321
Age range-based screening programs have been developed and are being implemented.

SE331
Targeted screening programs have been implemented. The screening population reach is over 70%.

SE333
Non-participating individuals have been identified and strategies to encourage participation are worked on.

SE334
Initial cost-effectiveness assessments have been conducted, providing insights into the efficiency of screening programs.

SE341
Over 85% of the population, is consistently reached with screening programs of the CCI.

SE342
Targeted screening programs have been implemented for individuals with increased risk of cancer.

SE343
Strategies to engage non-participating individuals are implemented.

SE344
More detailed and regular cost-effectiveness assessments are conducted to identify areas for improvement and resource allocation to enhance the efficiency of screening programs.

SE345
The CCI actively collaborates in data analysis of data from the screening population, contributing to research and continuous improvement efforts.

Continuous education and training in screening and early detection of professionals, patients, and citizens

SE312
Initial discussions have taken place about educating primary healthcare professionals on early detection.

SE313
First information on training programs for professionals related to the identification of high-risk populations was collected.

SE314
Initial discussions have taken place about educating patients in screening programs.

SE315
Initial discussions have taken place about educating patients in early detection.

SE316
Initial discussions about citizens' awareness have taken place.

SE323
Training programs for primary healthcare professionals have been developed and are being implemented to enhance early detection skills.

SE324
Formal training programs for professionals focused on the identification of high-risk populations have been established within the CCI.

SE325
Education in screening programs for patients are available in parts of the CCI.

SE326
Education in early detection for patients is available in parts of the CCI.

SE327
Citizens' awareness campaigns are performed in parts of the CCI.

SE335
Regular assessments of training programs in screening and early detection are conducted, and improvements are made based on feedback from professionals.

SE336
Education in screening programs for patients is available in the whole CCI.

SE337
Education in early detection for patients is available in the whole CCI.

SE338
Citizens' awareness campaigns are performed in the whole CCI.

SE346
Training programs are continuously refined and updated to align with the latest guidelines and best practices on screening and early detection.

SE347
Patient education is continuously refined and updated to align with the latest advancements in screening programs.

SE348
Patient education is continuously refined and updated to align with the latest advancements in early detection.

An error has occurred. This application may no longer respond until reloaded. Reload 🗙